UBS raises Altria stock price target to $83 on strong quarter
UBS raised its price target on Altria Group (NYSE:MO) to $83, citing strong Q3 2026 revenue growth of 3.6% and raised EPS guidance. The stock trades near its 52-week high, up 43% over the past year. Altria's dividend yield is 5.79%, and it has raised dividends for 16 consecutive years. Recent earnings beat estimates, with EPS of $1.52 and revenue of $6.13 billion. Goldman Sachs and BofA Securities also raised their price targets.
How this was made
The 30-second read
Why it matters
Analyst price target hikes signal near‑term upside potential for the stock.
Market read
Earnings beat and upgraded guidance drive bullish sentiment for MO.
What to watch
Possible future regulatory constraints on cigarette volumes could limit long‑term growth.
Background
Altria reported Q3 2026 earnings that beat expectations, prompting multiple analyst upgrades.
Ticker impact
UBS and other banks raised price targets on Altria (MO) after its Q3 2026 earnings beat and raised guidance.
likely upward pressure as the market prices in higher targets and improved guidance
Earnings beat, revenue beat, and raised guidance drive analysts to lift price targets, indicating bullish sentiment.
Market effects
Strong performance may lift other tobacco and consumer staples stocks.
U.S. market may see modest gains in dividend‑focused sectors.
Limited to U.S. equities; no broader macro impact.
Counterpoint
High dividend yield may attract income investors despite potential regulatory headwinds.
Key entities
- companyAltria Group Inc.
Tobacco and nicotine products company.
- analystUBS
Raised price target to $83.




